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INmODUCTION
1. Cancer
"Cancer has been defined by Willis 9 3 as an abnormal mass
of tissue, the growth of which exceeds and is uncoordinated
with that of norm.al tissues, and persists in the same excessive manner after the cessation of the stimuli which evoked
the change."
"Cancer is a disease of the cell that is transferred to
the descendants of the cell.

The disease is recognized by the

behavior· of a population of abnormal cells within a normal
tissue, as manifested by varying degrees of morphologic disorientation, aggressive growth and invasion, with ultimate
destruction of the normal cell population."1
"Cancer is a generic term for a variety of malignant
neoplasma, due to unknown and probable multiple causes, arising in all tissues composed of potentially dividing cells,
in man and other animals, and resulting in adverse effects on
the host through invasive growth and metastases.
'

'

of the major causes of death throughout the world.

It is one
In the

United States, deaths from' cancer are second only to cardiovascular and renal diseases.

Wherever malnutrition and other

socioeconomic factors, as well as infectious diseases, etc.,
result in a short average span of life, cancer is not an important health problem, in spite of increase in population.
Conversely, an increase of population that is associated with

2

an increase in life expectancy does bring a progressive in=
crease in the occurrence of oancero
paradox:

Thus, the inevitable

as public health improves, cancer becomes a greater

problemo 2
The progressive increase in the number of reported deaths
from cancer is, to a large extent, only apparent, for more
oases are being diagnosed accurately as the public and the
medical profession become cancer conscious and as more accurate methods for diagnosis become available.

The mortality

from cancer is also due to an increase,.in the numbers of individuals reaching advanced age.

In the.United States there

were 13 million persons 45 years of age or older in 1900; by

1948 there were 39 million persons .1n,tbat age group and in
1958 there were

50

million.

In view of the fact that cancer

is prevalent among aged individuals, cancer cases may continue
to increase in the United States !'or a number of years on the
basis of these !'acts alone.

In addition, there appears to be

a true increased incidence of certain forms of cancer.
The outstanding recent changes in cancer morbidity and
mortality are as followsg

(1) a threefold increase in cancer

of the lung among males, (2) a twofold

increase in leukemias

and "lymphomas,u (3) a 30% decrease in cancer of the stomach,
and (4) a 30% decrease in cancer of the cervix.

Also, the

gap among the greater probability of cancer in females and
the lesser one in males bas been closing due mainly to the
increase in pulmonary cancer in men.

More than half of the

3
cancer risk in men is due to oanoer of the skin, prostrate,
lung, stomach, and intestine, whereas more than half of the
cancer risk in women is due to cancer of-the breast, intestine,
skin, and cervix uteri.

During a lifetime one in every four

women and one in every five men maf be expected to develop
cancer.

The increased risk is due in part to the decline of

noncancerous causes of death."3

2. Chemotherapy of Neoplastic Disease
"Although great strides have been made in the chemotherapy
of neoplastic disease, the sobering fact must be realized that,
after the diagnosis has been made, only 20 per cent of all
patients are salvaged for five years by currently available
therapeutic measures.

Inasmuch as surgery and radiotherapy

have been developed to a high degree of perfection, it is
obvious that major advances must be sought in other fields.
Methods for early diagnosis and effective chemotherapy could
obviously make great contributions.
It should be stated at the onset that, with the exception
of early childhood leukemia (which can be cured by folio acid
antagonists), no chemical compound bas yet been found which is
I

capable of curing any form of

cancer~

However, various drugs

and hormones are available which can induce temporary remissions
in certain types of neoplastic disease.

Other agents are of

value in that they appear to support the host against the
ravages of the disease.

Drugs capable of inducing temporary

4
remissions can be divided into three classes.

(1) Cytotoxic

agents which exert their actions by virtue of their chemical
properties:

as a group these compounds lack selectivity of

action in that they are toxic to normal as well as malignant
cells.

However, they are of some therapeutic value inasmuch

as the vulnerability of cells appears to be related to their
rate of mitotic activity.

(2) Cytotoxic agents which exert

their actions by virtue of their physical properties:

this

group comprises the radioactive isotopes, which exert their
effects through ionizing radiation •. Radioactive isotopes also
lack selectivity of action, but in a few . instances advantage
can be taken of the selective distribution of a particular
element in the body to attain relatively high concentrations
at a desired site.

(3) Agents which exert their action by

altering the environment of the cancer cell:

this group com-

prises certain hormones, notably estrogens, androgens, and
adrenocortical steroids.

Altering the hormonal environment

with respect to estrogens and androgens is of some value in
the control of neoplasms of the secondary sex organs.

Induced

hypercorticism provides an unfavorable environment for certain
malignant growths involving hematopoietic tissue."45

5
Purpose and Soope of the Research
In August, 1965 Andrew Bachmann presented a tlwsis based
on the fact that indole was selectively absorbed in the cancer
tissue.

This paper is similar in that indole is used as the

means of transport to concentrate the alkylating agents in the
tumor.

The alkylating agents presented in this paper are ep-

oxides and methane sulfonateso
The historical portion of this paper is designed to show
the value of epoxides and methane sulfonates in chemotherapy.
The experimental portion is composed of the synthesis of these
com.pounds, related intermediates, and a new color test which
is a potential method for the detection of indole in a tum.or.

6

HISTORY
Evidence for the Association of Indole
With Tumor Cells
"Indole has been tested for its anti-cancer properties
and found lacking.

However, it was found that lipotropic

ccH20H, chloretone
3
and indole, which greatly inhibit brain respiration, also

materials such as amytol, phentothal, Br

markedly inhibit the respiration of Erlich Ascites tumor cells.
These compounds inhibit the intake of glycine into these cells
under anaerobic conditions in the presence of glucose, the extent of inhibition being greater than that of anaerobic glycolysis.

It is suggested that respiratory mechanisms and the

transport system of the whole cell depend for their activities
on the lipid components of the cell membrane structures with
which these lipotropic agents become associated, thereby decreasing these activities."15

Review of Related Work from
Potential Neoplasm Inhibitors I
A suspension of indole containing radioactive

c14

was

administered to a female C3H mouse by intraperitoneal injection
by Bachmann and the following data were collected.

Bachmann

found about a 17:1 concentration ratio of indole in cancer
tissue as opposed to similar muscle tissue.

The indole con-

centration remained at a high level for about twelve (12) hours.

7

Then over the next seventy-two (72) hours$ the indole appeared
to be removed and detoxified by the liver.
The fact that the indole content of the corresponding
muscle tissue was always so small indicated that the pH induction of the tumor had indeed been used to cause a selective
deposition.

To Bachmann•s knowledge, this was the first instance

that such an effect had been observed.
"Nitrogen mustards and alkyl methanesulfonates will react
with the hydrophobic constituents of a living cell in considerably less than twelve (12) hours, which is the time limit
for the maximum concentration of indole.

Therefore, the indole

moiety should act as an effective transport molecule for alkylating substituent should combine with the cell wall, if indole
concentrates there, and change its character enough to inhibit
cell

respiration~

failure.

thereby killing the cell through respiration

If indole concentrates elsewhere in the cell, the

alkylating substituent should interrupt metabolic pathways
resulting in the death of the cell.''
Bachmann also suggested that if a gamma ray emitter were
placed upon an indole molecule, the resulting molecule might
serve as a locator for tum.ors.

To investigate this idea,

5-iodoindole was synthesized which contained

iodine-125~

encouraging, data on this experiment was not conclusive. 16

Though

8

Influence of pH on Reactivityg

17 ' 51

"In Warburg 1 s studies on tumors .11 the observation was made
that, whereas both normal and tumor tissues produced lactic
acid from glucose or glycogen in the absence of oxygen, practically only cancer tissue showed the ability to produce lactic
acid from glucose in the presence of oxygen.
The respiration ratio of cancer and of normal tissues
appeared to be very nearly of the same order of magnitude,
and to account for the high aerobic glycolyais in tumors
Warburg postulated that the respiratory mechanism is such
tissues was damaged as a result of the neoplastic transformation.

High anaerobic glycolysis appeared to be a general

property of growing or multiplying tissues, since it was
found in embryo tissue and testes, but in these normal tissue
glyoolysis was largely abolished by the presence of oxygen.
In most tumors, the high anaerobic glycolysis was relatively
little reduced when oxygen was admitted to the system.
That lactic acid is actually produced from tumors was
shown by several investigators who observed that the venous
blood leaving a ttllllor contained less glucose and more lactate
than did venous blood in a comparable tumor-free site in the
same animal.
Since lactic acid is a relatively strong organic acid,
its accumulation within the tumor should produce a lowering
of the pH, provided that the rate of glycolysis exceeds both

9
the diffusion of buffers from the arterial oirculation into
the cells and provided that the rate of S1!lpply of the glucose
to the cells is sufficiently high.
By inserting electrodes directly into the tumor mass of
the living animal, Voegtlin et !.! demonstrated that the administration of glucose, whether subcutaneous or intraperitoneal,
was followed very quickly by a drop in pH of

0.4

to 0.6 unit.

The pH of the tumor may drop from 6.9 to 6.3 without the occurrence of any pulmonary respiratory symptoms indicative of systematic acidosis, thus indicating that the increased acid production is largely confined to the tumor and that the excess
lactate carried off in the venous circulation is quickly metabolized by the normal tissues.
Kahler and Robertson compared the hydrogen ion concentration of the liver and of a transplanted heptoma in fasted
rats.

The pH of the liver was 7.4, that of the tumor 7.0.

When the rats were supplied with excess glucose, the pH of
the liVer remained unaltered whereas that of the heptoma dropped
to

6.4"

10

Alkylating Agents
1) Epoxides 91
There are two (2) possible mechanisms by which an epoxide
can react with a nucleophilic centre (A=) in neutral solution.
_..+_A_-->~

Slow

/?"

R•CH°CH A

I

2

oThe first is a unimolecular process which would only be
favored if the terminal carbon atom were substituted, and the
second is a typical Sn2 substitution as shown above.

74

The Sn2 mechanism may be explained more clearly by the
following:

x- +

R-Y

---->'!'I>

R-X + Y-

IJ.he complete separation of R and Y does not occur, but a
transition state occurs in which R is loosely combined with both
X and Y.

The attainment of the transition state is also assisted

by solvation of the polar complex and in the subsequent process
desolvation, charge transfer, and bond formation are involved.
Effectively a carbonium ion R+ is again trana~erred from Y to
X but in this case it is at no time free in the sense of being
detached from Y, for the bond forming and bond breaking processes occur simultaneously.

In the rate determining formation

of the transition complex two molecules are undergoing covalenoy
change.

A feature of the Sn2 reaction is that the rate is de-

pendent on the concentration of the displacing group

x-

and upon

11

its affinity for the electrophilic R+.
the attack of the nucleophilic group

x-

The driving force is
on a carbon atom in

the R group of the alkylating agent and the extent of the reaction will depend on the
of groups

x-

~elative

nucleophilic capacities

and Y-. 72

Epoxides are relatively slow to

react~

the half-life of

diepoxybutane is about 100 hours at 37°c in purely aqueous
solution.

The reaction rate.will be increased by the presence

of reacting groups, since for terminally unsubstituted derivatives the Sn2 mechanism operates.

Actually, only terminally

unsubstituted compounds are of interest biologically.

We thus

have a group of moderately reactive alkylating agents which
are effective under biological conditions and which are transported as neutral molecules; the rate of reaction will depend
on the concentration of reacting centres.
The reagents which react by the Sn2 route can be removed
quickly at sites of high nucleophilic potential.

The virtue

of the slower reacting epoxides may be that they survive long
enough to alkylate target sites at distant regions.

Henry,

Rose, and Walpole {1950) suggested that cytotoxic alkylating
agents polymerize in

~'

giving a structure containing

reactive groups which are spaced at approximately 7.62 apart.
This repeat distance is similar to that of the side chains
in a fully extended protein or the internucleotides in a nucleic
acid.

Multipoint attachment of the polymer to either of these

macromolecules in a chromosome structure was thought to be

12
responsible for the induced mitotic abnormalities. ~

Effect of pH on Reactivity of Epoxides
Some simple epoxides have a high rate coefficient for
acid catalysed type of reaction.

This type of compound would

be expected to react more readily with

nu~leophilio

regions where the acidity is relatively higher.

centres in

For those

groups with pKa somewhat removed from physiological pH, such
as phosphate groups, carboxyl

groups~

and relatively weak basic

groups, the effect of the limited pH change on ionization will
not be significant.
A careful study of certain basic diepoxide derivatives
by Gerzon et !1_. (1959) has shown how another structural modification may be introduced in order to obtain acid-enhanced
reactivity.

Ross (1950) had shown that the incorporation of

a charge onto the nitrogen atom of the methiodide of N,N-ai(2,J-epoxypropyl)-p-anisidine enhances the reactivity of the
epoxide ring.

This effect is independant of the rate enhancing

effect of pH change alone.

Some correlation between basicity,

rate of reaction with phosphate ion, and antileukemic activity
was established by Garzon!..:!! !1_. (1959) and it would seem profitable to extend the study of these basic epoxides to the treatment of solid tumors, especially after pretreatment of the host
with glucose. 77
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Effects on Protein Synthesis and on Respiration
Butadiene dioxide inhibited the .!!! vitro incorporation
of glycine-1-c 14 into the proteins of Ehrlich ascites carcinoma cells but had no effect upon the rate of respirationo33

Reactions With Proteins and Compounds Containing
Functional groups That Occur in Proteins
It bas been shown that epoxides can react with various
proteins including casein, 1 9 egg albumin,43 bovine serum
albumin,4 161718 B- lactoglobulin,4 3 wool, and human hair.30
Tests for functional groups of the proteins showed that alkylation of the following types of groups occurred: Carboxyl,5,7
phenolic,43 amino, 61 7,43 imidazole6,7 and sulfhydryl.6 Ep58
oxides reacted with esters of amino acias
to yield disubsti8
tuted amino compounds5 and lactones.59 Reaction with thioamides and thiols yielded 2-bydroxy-alkyl sulfides34 and reaction
with pectic acid resulted in esterification.3 6 Thus, reaction
can occur with a variety of groups occurring in proteins, and
if polyepoxides are used, cross-linking of proteins may
occur.4,a,4 2 Very little deactivation of cholinesterase
occurred, bowever. 27

Cytologic and Mutagenic Effects
Glycidol caused chromosomal bridging and breakage in
cultured S-180 ce11 20 and the administration of butadiene

dioxide to male mice interfered with spermatogenesis and caused
chromosome breaks. 66 Epoxides have been shown to be effective
mutagens in a variety of biological systems including
Drosophila Melanogaster, 22 , 2 3 Neurospora crassa,57, 61
Penicillium Chrypogenum,54 Escherichia coli, 8 7 and tomatoes.4 1

Reactions With Nucleic Acids and Nucleic Acid Moieties
Bifunctional epoxides reacted with nucleoproteins in
solution to cause the formation of a gel, and the alkylation
occurred exclusively with the DNA portions of the molecules7,ll,l 2
This gel formation was probably the result of cross-linking of
DNA molecules. There is some evidence that alkylation of both
nucleoprotein 7 and DNA 9 occurred at the phosphate groups with
the resulting formation of esters.

These esters might in turn

alkylate the ring-nitrogen atoms of _the purines, which resulted
eventually in scission of the ribose-phosphate chain of the
DNA.9

Treatment of guanosine with ethylene oxide and propylene

oxide in unbuffered solution at 37°c yielded a product that was
spectrally similar to 7-methylguanosine. 63

Treatment of tobacco

mosaic virus RNA with ethylene oxide or propylene oxide caused
deactivation of the reconstttuted virus,44,45 when as few as
1-3 molecules of the epoxide had reacted with one molecule of
the RNA, and it appeared that the guanine moieties were the
chief sites of reaction.44
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Effects on Fertility
Fahmy and Fahmy (1958) have made related studies on the
action of different alkylating agents on different stages of
cell development in the germinal tissue of Drosophila males.
The adult males were injected with the agent and the germ line
was fractionated by repeated matings to a succession of virgin
females.

The mutation rate fluctuated in successive broods.

It is believed that since the sperm used in the sequential
matings time of treatment, the variation in brood mutation
response probably reflected the relative.susceptibility of
the various cell stages to the action of the mutagenic alkylating agents.
Diepoxides and most simple mustards produce a maximum
effect on early spermatids and little action on spermatocytes
and spermatagonia.78
2) Methanesulphonates73,B7
Esters of alkanesulfonic and arenesulfonic acids are
alkylating agents because in reaction the alkyl-oxygen bond
undergoes fission.

Methyl esters react with nucleophilic

centres by a bimolecular mechanism previously discussed in
this paper. 82 Therefore, the chemical reactions of the sulfonic
esters are generally similar to those of the epoxides.
In the series CH3so 2 o(CH2) 0 oso 2 cH , the chemical reactivity
3
is low in compounds (n=2 and 3) due to the mutual deactivating
effect of the methanesulfoxy groups.

From n=4 upwards the

16

chemical reactivity is higher and more uniform.

76

Distribution and Fate of Administered Sulfonic Esters
The compound,

s35 -

labeled tetramethylene ester of

methanesulfonic acid was administered to rats, mice and rabbits
and the data were collected.
tive concentration of the

s35

In the rat there was some selecin the spleen and bone marrow,

but 32 hours after injection, 95 per cent of the
in the urine.
liver proteins.

Small amounts of

s35

s35

was present

were associated with the

Following the administration of this agent

to humans the s35 disappeared rapidly from the blood and 45-69
per cent of the

s35

was present in the urine in 48 hours.68,69

Tetramethylene ester of methanesulfonic acid labeled with

c14

in the 1 and 4 positions was also injected into rats and

the data were collected.

The specific activities of the kidneys,

lungs, and liver were higher than those of the other tissues
examined, and in the liver only small amounts of radioactivity
were associated with proteins, fats and sodium nucleates.
Within 24 hours 12-14 per cent of the injected c1 4 was excreted
as carbon dioxide, 22-36 per cent was in the urine, and 3-8 per
cent was in the feces.83,89

Effects on Glycolysis and Respiration
1,9-Di-(methanesulfonxy) nonane depressed the respiration
of ascites~tumor\cells'.and promoted aerobic glycolysis 60~80

17
per cent but had no influence or anaerobic glycolysis.3 9
other methanesulfonyl esters acted similar.

Several

Kinetic studies

with enzymes led to the conclusion that the inhibition of respiration by beta-chloroethyl methanesulfonate was chiefly due
to physical effects of this agent upon the hydrogen transport
chain of the cell. 25

Effects on Protein Synthesis
The majority of the esters of methanesulfonic acid had
little or no significant effect on protein synthesis.

Deactivation of Enzymes
Several methanesulfonic esters had very littl~ anticholinesterase activity, 2 7 but tetramethylene ester of methanesulfonic acid inhibited crystalline triosephosphate dehydrogenase. 55

Reactions With Proteins and With Compounds Containing
Functional Groups that Occur in Proteins
Evidence has been obtained that tetramethylene ester of
methane-sulfonic acid can react with the protein portion of
nucleoproteins,28 and several meth11nesulfonic esters reacted
with the mercapto groups of denatured egg albumin and with
carboxyl and imidazole groups but not the amino groups of
bovine serum albumin. 6 '7 The reactions possibly cause dethio-

18

lation of proteins, but the biological significance of such
dethiolation is not yet known.

Antimitotic, Cytologic, and Mutagenic Effects
Tetramethylene ester of methanesulfonic acid inhibited
6
the mitosis of cultured fibroblasts, 31 ' 32 ,4 and 1,4-dimethyltetramethylene ester of methanesulfonic acid inhibited cultured
11
leukemia cells.
Experiments with tetramethylene ester of
methanesulfonic acid and tritiated thymidine showed that synthesis
of SNA by fibroblasts could occur even when the mitotic activity
was reduced.3l,3 2 Among the cytologic effects noted for the
tetramethylene and 1,4-dimethyltetramethylene esters of
methanesulfonic acid on mannnalian cells were giant cell formation, 10 nuclear enlargement,4 6 multinucleation32 ' 35 chromosome
br~aks,

46

and chromosome bridges.

46,37

Concerning the mutagenic

effect, it is of interest that radioactivity was detected in the
testicles of mice following the injection of 1,4-dimethyltetramethylene ester of methanesulfonic acid.

Effects in Synthesis of Nucleic Acids
Tetramethylene ester of methanesulfonic acid had only a
slight or no inhibitory effect upon the de B.Q.Y£ synthesis of
nucleic acid purines.

The lack of inhibition of the synthesis

of nucleic acids is consistent with the observation that the
incorporation of tritiated thymidene into the nuclei of cultured

19
cells in the presence of tetramethylene ester of methanesulfonic
acid occurred even after mitotic activity was greatly reducea.3l,3 2

Reaction With Nucleic Acids and Nucleic Acid Moieties
After treatment with tritiated tetramethylene ester of
methanesulfonic acid, tritium was found localized in the nuclei
of the root tips of Vicia

~,

whereas no tritium was detected

in the cytoplasm. 67
There is also evidence that sulfonic esters can react with
DNA in vitro.

Alkylation of DNA with methyl methanesulfonate

and with ethyl methanesulfonate caused an immediate decrease in
viscosity of the solution, perhaps because the DNA molecules
become more highly coiled.

It was suggested that the initial

site of alkylation might be the phosphate groups of the DNA
with subsequent alkylation of the purine-ring nitrogen atoms
by the tri-esters; alkylation of the purines could then result
in expulsion of the quaternized purine and rupture of the
desoxyribosephosphate chain.

9
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Preparations and Reactions
of ·Related Compounds
1.

Reactions cf Epichlorohydrin with Secondary Amines 38 ' 18 ' 40
(1) Secondary amines react readily with excess
epichlorohydrin to yield mainly amino chlorohydrin
as indicated below:

With alkali, the epoxy ring is closed to yield an
epihydrinamine as shown below:

The latter products condense with another secondary
amine to yield unsymmetrical 1,3-diamino-2-propanol
according to the following equation:

2.

Preparations of Methane Sulfonates
There are three general methods for the preparation of

methanesulfonates.
(1) Refluxing methane sulfonyl chloride with an alcohol,
or reacting in pyridine.79

21

(2)

Refluxing an alcohol with methane sulfonic acid
to give poor yields. 1 3

ROH

+

+

HOH

(3) Refluxing the silver salt of methane sulfonic acid
with an alkyl chloride.47,86

3.

Mannich Reaction
(1) The beta or

3-pos~tion

in indole is very reactive and

with formaldehyde and dimethylamine in the presence of
acetic acid undergoes the Mannich reaction to form the
(3-dimethylaminomethylindole), gramine. 2 9

+
H

+

/H3
CHJ
~H2 -N
.~--.-,:;:. ~ \n3

CHJ

H

+

H2 0

22

(2) The study of reaction of chromones--with formaidehyde
and a secondary amine hydrochloride by the Mannich
reaction. 92

R=methoxy, alkyl,

halog~n

or hydrogen

R' =Alkyl

4.

Schiff Base4 9 , 5o
(1) The conversion of a primary amine into an aldimine by
condensation with an aldehyde.

R = Phenyl and Aliphatic

(2)

Preparation of a ketimine by reaction of a primary
amine with a ketone.
Rt

RNH

2

5.

+

':c=o
RY

>

RN=C/

R'

"-R•

Reduction of Schiff Bases with Sodium Borohydride 21 ' 56
H
(1) Ar-CH=N-Ar 1 NaBH1··
.r
Ar-C~N-Arl
Where Ar and Ar 1 may be a phenyl group or a nitro-,
ohloro-, methoxy-, or hydroxyphenyl group.
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The yields range from 81-90% and the reduction condition
aren•t too critical.

It was found, however, that the

reaction proceeded more readily in ethanol than+meth anol.
0 i-~
MeOH )
PhCH -N-CH HCl :):i PhCh2 -N-CH
(2) PhCH=N-CH3
2 H
3
oo
3
I
NaBH
H

4

The mixture comes to room temperature and is then heated
for two (2) hours at 50°.

The methanol is removed and

product extracted with ether.

The hydrochloride is

formed by treating with HCl gas.

Previous Color Methods for the Detection of Indole
Several color tests have been developed for the detection
of indole derivatives.

These include a test which employs a

color reaction between indole and a eerie nitrate reagent by
2
Hartough.5
Anger and Ofri describe a reaction test, yielding
a red color, by reaction of an indole derivative with pyridyl1
pyridinium chloride. 4 Sawicki obtained a blue color by reaction
of 3-meth11-2-benzothiazolone with indole. 83 The indole ring in
reserpine was detected by Haycock and Mader by reaction with
dilute nitrous acid.53

When heated with Arreguine's reagent

(glacial acetic acid, concentrated hJdrochloric acid, and
:mn:tbydrol) a color reaction is given by indole.

8

4

A test using

a chloroform solution of piperonal, phosphorous pentachloride,
and trifluoroacetic acid bas also been used.71

24
Discussion and Experimental
In the present study it was found that butyl nitritej
acidified with concentrated hydrochloric acid, gave a color
reaction test for indole and many indole derivatives.
Early in this work it was found ·that the test is sensitive
for indole in the presence of freshly dissected liver, stomach,
and kidney of a normal mouse.

Repetition of the test with a

cancerous mouse showed that after twenty (20) hours the indole
was concentrated in the tumor, and it was not detected in the
liver or kidney.
The procedure using normal mice is described below:
To a solution of 6.5ml of polyethylene glycol (PEG-300)
was added 100 mg of indole and
solution.

A

0.5

5.5

ml of sterile glucose

ml sample was taken from this solution and

injected into the abdomen of each of two (2) normal mice
which had been previously starved for two (2) hours.
One of the mice became a little sick and was sacrificed
(chloroform) after one-half hour.

The liver, stomach, and

kidneys were removed, placed in three (3) separate beakers,
each containing

50

ml of ether.

The tissues were crushed,

removed from the extract, and the ether evaporated to near
dryness by means of a hot-water bath.
was made by dissolving the residue in

The test for indole

5

ml of ethanol and

adding two (2) drops each of butyl nitrite and concentrated
hydrochloric acid.
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Results of Test on First Mouse:
Liver

Negative, no color was observed.

Stomach

Negative, no color was observed.

Kidney

Negative, no color was observed.

When no test was given for indole, the remainder of the
mouse was placed in a beaker and extracted with 100 ml of
ether.

The ether was evaporated and the color test was

repeated.
Results:
Body cavity of the mouse --- A positive test {red color)
was obtained.
Two (2) hours after the injection, the second mouse was
sacrificed (chloroform) and dissected.

The kidney, liver, and

stomach were removed and placed in three (3) separate beakers,
each containing

50

ml of ether.

removed from the ether extract.

The tissues were crushed and
The ether was then evaporated

to near dryness on a hot-water bath and the residue dissolved
in ethanol.

The solution was tested using butyl nitrite and

concentrated hydrochloric acid.
Results:
Liver

Positive, a red color was observed.

Kidney

Positive, a red color was observed.

Stomach

Positive, a red color was observed.

Since the test showed that indole can be found in the
dissected organs of a normal mouse, it was decided to repeat
the test with cancerous mice.

The procedure is described
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as follows:
To a solution of

6.5

ml of polyethylene glycol (PEG-300)

was added 100 mg of indole and
aqueous solution.

A

5.5

ml of sterile saturated

0.5 ml sample was taken from this

solution and was administered to cancerous C3H mouse which
had been previously starved for two (2) hours.

After a period

of thirty (30) minutes, another cancerous C3H mouse was injecetd
using the same procedure as described above.
The first mouse died approximately one-half hour after
injection.

The mouse was dissected; the liver, kidney, tumor

and corresponding muscle tissues were removed, extracted with
ether, and tested using the butyl nitrite-hydrochloric acid
test.

The results are shown below:
Tumor

Negative, no color was observed.

Kidney

Negative, no color was observed.

Liver

Negative, no color was observed.

Muscle

Negative, no color was observed.

After a period of twenty (20) hours, the second mouse was
sacrificed (chloroform) and dissect.ad.

The kidney, liver, tumor,

and corresponding muscle tissue were removed, extracted, and
tested using the butyl nitrite-hydrochloric acid test.

The

results are shown below:
Tumor

Positive, an orange-red color was observed.

Kidney

Negative, no color was observed.

Liver

Negative, no color was observed.

Muscle tissue - Negative, no color was observed.
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Since indole was shown, by the butyl nitrite-hydrochloric
acid test, to concentrate in cancerous tissue in mice, several
derivatives of indole and of related compounds were purchased
or prepared for this study.
Initially, it was planned to teat each compound purchased
or prepared in a cancerous mouse, and a few were

However,

test~d.

the butyl nitrite-hydrochloric acid test offered such a rapid,
convenient. and inexpensive method to test indole and related
compounds, in vitro, it was employed as a guide to predict
.whe.ther or not these particular compounds should be used in
the animal test.
The following compounds were prepared for injection into
cancerous mice.

H

To 3.92 grams (0.02 mole} of tryptamine hydrochloride
was added

50

ml of water and 20 ml of 95% ethanol.

The reaction

mixture was stirred, warmed and made distinctively basic by the
addition of a saturated solution of potassium carbonate.
oily layer which separated was extracted into

40

The

ml of ether.

The ether solution was added dropwise to 3.79g (0.042 mole) of
epiohlorohydrin in 20 ml of
to stand overnight.

95%

ethanol.

The mixture was allowed
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The reaction mixture was diluted with 250 ml of water,
then treated with 100 ml of ether and 10 ml of glacial acetic
aoid.

The upper layer was extracted with 100 ml of 10% acetic

acid, and the aqueous acetic acid portions were combined and
treated with excess 6X sodium hydroxide solution.

The oily

layer which separated was taken up in 100 ml of ether.

The

ether extract was filtered and treated with approximately 12
After three (3) days in the

grams of sodium hydroxide pellets.

refrigerator and the addition of 125 ml of ether, the solvent was
filter,ad, the ether evapora-ted·on
wa~.left

a

bot-water bath, and· the residue

overnight in a flask·!n a vacuum desicator.

clear oil was 1.70 grams .t33%.yield).
titrateable N,

5.50%.

Found,

The yield of

Calculated for

c1 6n20 N202g

4.9%.

Sodium 3 2(3-indoly)ethylamino propane sulfonate.
CH2 -cH2ycH2 CH CH2 so 3Na
2
H
H

To l.81 grams (O.Ol mole) of tryptamine hydrochloride
was added 20 ml of water and 10 ml of

95%

ethanol.

The reaction

mixture was warmed, stirred, and made distinctively basic by
the addition of a saturated solution of potassium carbonate.
The oily layer which separated was extracted into
ether.

40

ml of

The ether and ethanol were removed by means of a rotary

evaporator, the residue dissolved in 5 ml of absolute methanol
and added to 0.61 gram (0.005 mole) of propane sultone dissolved
in 10 ml of absolute methanol.

The reaction mixture was allowed
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to stand at room temperature for three (3) days.

The ether

and ethanol were removed by means of a rotary evaporator.

To

the product (3.6 grams) was added 10 ml of methanol, and the
mixture was warmed.

Then, 14.5 ml of O.lN sodium methoxide

( 0.115 g of sodium metal in

50

was swirled and cooled in an

ml MeOH) was added; the mixtux•e

ice-water bath.

A crystalline

product could not be obtained; therefore, the mixture was
triturated with ether.

An oily, sticky product was obtained.

The ether and water were decanted oft;, and the product was dried
in a flask in a vacuum desicator.
1.22 grams (40% yield).
tritrateable N, 4.60%.

The yield of the oil was

Calculated for

c13 H17No

3

sNa:

Found 4.2%.

Methyl-2-furylmethyl-2,J-epoxypropyl amine

To a three-necked liter flask with a thermometer and
mechanical stirrer attached was added 27.75 g (0.3 mole) of
epichlorohydrin.
cooled to 4°c.

The flask was placed in an ice bucket and
From a dropping funnel 33.3g (0.3 mole) of

N-methylfurfuryl amine was added slowly, keeping the temperature
below 30°c.

To catalyze the reaction, approximately 0.5ml of

water was added.

The reaction mixture was stirred, and the

temperature kept below 30°c for one and one-half hours.

The

mixture was then cooled to 10°, and 16 g (0.4 mole) of sodium
hydroxide in

25 ml of water was added batchwise, keeping the
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temperature below

25 0 .

The reaction mixture was then extracted
I

I

with three (~) 150 ml portions of ether, the three (3) ether
portions combined, placed over sodium hydroxide pellets, and
left to stand in the refrigerator overnight.
The mixture was filtered by gravity and the ether removed
by means of a rotary evaporator, without heat.
then distilled under reduced pressure (J5mm),

The.mixture was
~p

The yield of clear oil was 30.88g (61.4% yield).
for c H13 No :
2
9

tritrateable N, 8.38%.

0

145-80 •
Calculated

Found 8.22%.

2-Furylmethyl-bis(2,3-epoxypropyl)amine

0

CH2-N(CH2-c'-\rn2>2

To a three-necked liter flask with a thermometer and
mechanical

~tirrer

epichlorohydrin.

tor:•4°o

attached was added 55.5g (0.6 moie) of
The flask was piaced in an ice bucket and cooled

From.a.funnel 29.1 g (0.03 mole) of furfuryl amine was

added slowly with stirring and cooling, keeping the temperature
below 30°0.
the reaction.

Approximately 0.5ml of water was added to catalyze
The mixture was

stirred overnight and left to

stand over the week-end.
The mixture was stirred again, cooled to l0°c,apd J2g
(0.8 mole) of sodium hydroxide in 60 ml of water was added
batchwise, keeping the temperature below 20°.

After one hour

of mixing, the reactiop mixture was diluted with 100 ml of
water and extracted with three 150 ml portions of ether.
three portions of ether were combined, placed over sodium

The
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hydroxide pellets, and left to stand overnight in a liter flask
in the refrigerator.
The mixture was filtered by gravity and the ether removed
by means of a rotary evaporator without heat.

The mixture was

then distilled under reduced pressure (0.1 mm), bp 143-6°.
yield of clear oil was llg (17.6% yield).

c11H15No

3

:

titrateable N, 6.69%.

The

Calculated for

Found, 6.6%.

The four (4) synthesized compounds were tested in cancerous
C3H mice as previously described.

The following results were

observed.
(1) 3-Indolylmethyl-bis(2,3-epoxypropyl)amine
Tumor

- Positive, but only a slight color was observed.

Liver

- Positive, but only a very slight color was observed.

Muscle

- Negative, no color was observed.

(2) Sodium-3-2(3-indolyl)ethylamino

propane sulfonate

Tumor

- Positive, a beautiful red color was observed.

Liver

- Negative, no color was observed.

Muscle

- Negative, no color was observed.

(3) Methyl-2-furylmethyl-2,3-epoxypropyl amine
Tumor

- Negative, no color was observed.

Liver

- Negative, no color was observed.

Muscle

- Negative, no color was observed.
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(4) 2-Furylmethyf-bis{2,J-epoxypropyl)amine
Tumor

- Negative, no color was observed.

Liver

- Negative, no color was observed.

Muscle

- Negative, no color was observed.

The procedure for dissection and testing these compounds
previously described proved rather tedious.

Therefore, the

following compounds were purchased and tested, in vitro, by
the butyl nitrite-hydrochloric acid test with the results indicated below.
The following compounds gave a positive test in vitro:
Gramine
Indole-J-carbinol
Sodium-N-tryptamine-gamma-propane sulfonate
2-Methylindole
3-Methylindole
7-Methylindole
N-Beta hydroxyethyl-2,3,4,5-tetramethylpyrrole
The following compounds gave slightly or doubtful tests:
3-Indolebutyric acid
3-Indolepropionic acid
5-Bromoindole
Tryptophol
5-Hydroxyindole
5-Am!noindole
2-1ndoline Sodium Sulfonate
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l-Acetyl-2-Indoline Sodium sulfonate
Pyrrole
The following compounds gave a negative test:
2-Indolecarboxylic acid
3-Indolecarboxylic acid
1-Indoleacetic acid
3-Indoleacetic acid
3-Indolecarboxaldehyde
5-Hydroxy-3-indoleacetic acid
The basis of this present study is the possibility of
getting alkylating agents selectively in the cancer cell.

As

was shown by A.G. Bachmann in 1965 (Potential Neoplasm Inhibitors),
indole and certain indole derivatives are selectively absorbed
in cancerous tissue at a pH slightly lower than that of a normal
cell.
The desired derivatives of indole were epihydrinamines,
beta-chloroethylamines, and methanesulfonates.

To make the

epihydrinamines and beta-chloroethylamines as intermediates,
it was necessary to have basic primary amino groups or basic
secondary amino groups, preferably the latter.

For the meth-

anesulfonates, alcohols were the intermediates.
In some cases satisfactory preparations were not obtained
for the products which are potential carcinolytic agents.

The

synthesis of the potential intermediates are given, however, as
a guide to future work.

Also, the chemical activity of some

of the potential carcinolytic agents was so great that isolation
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of the compound was not successful.

In such cases derivatives

were made which required as intermediates the desired active
chemical.
The following intermediates were prepared:
3-Indolylmethylbutyl amine

~- CH2~-c 4H9
I

H

To a solution of 23.4g (0.2 mole) of indole-3-carboxaldehyde dissolved in 25 ml of methanol was added 16.7g
(0.22 mole) of Q-butylamine.

The mixture was heated over a

hot-water bath for approximately 10 minutes.

To this mixture

was added slowly a solution of 16g sodium borohydride dissolved in 200ml of methanol, made basic with sodium hydroxide.
The resulting mixture was allowed to stand overnight.

The

mixture was refluxed gently for one hour, cooled, and diluted
to 500 ml with water.

An oil formed which settled to the

bottom of the container.

The solution was acidified and the

oil dissolved in the acidic layer.

The solution was then

extracted with two 250 ml portions of ether.

The acidic

layer was made basic with 6N sodium hydroxide and an oil
which separated was extracted with 30 ml of ether.
was removed on a hot-water bath.
12.2g (30% yield).
6.93%.

Calculated for

Found, 7.09%.

The ether

The yield of the oil was

c13H1 aN2 :

titrateable N,
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!!_-Butyl-3-indolylmethyl-2-(4-methylpiperizino)ethyl amine

c: H~ ~ C'f-H1

H

~H~J\,

e H4-,\_J- cH3

To a solution of 12.2g (0.06 mole) of 3-Indolylmethylbutyl amine in 5 ml of methanol was added very slowly with
swirling 17.4g (0.11 mole) of beta-chloroethyl methanesulfonate,
and it was left to stand overnight.

To this mixture was added

slowly with stirring 5g (0.05 mole) of N-methylpiperazine.
The reaction mixture was heated on a hot-water bath near 80°
Approximately 125 ml of 10% acetic acid

for about 20 minutes.

was added and the mixture
ether.

treat·ea

with two 50 ml portions of

The aqueous-acid layers were treated with 6N sodium

hydroxide solution, and a deep red oily layer separated.

On

treatment with 25 ml of ether, the product crystallized.

The

solution was filtered; the crystalline product was dissolved
in dilute acetic acid and extracted with 6N $Odium hydroxide
and extracted with ether.

The crystalline product which pre-

cipitated was J.7g (23% yield).
titrateable N, 12.80%.

CH)
<H)
-bH-N-

Calculated for

Found, 12.28%.

3-(Isopropylaminoethylidene)-indole

I

,.,
I

H

H

HJ

85a

c20H32 N :

4

A solution of 46.9g (0.40 mole) of indole in 240 ml of
glacial acetic acid was chilled and stirred while 26.4g
(0.44 mole) of isopropylamine was added.

To this cold solution

was -added a solution of 18.6g (0.416 mole) of acetaldehyde in
80 ml of benzene.

The reaction mixture was poured into
water and 50 ml of ether.
extracted with two 125 ml
The combined

~queous

portions of .e_ther,

o0 •

The mixture was allowed to stand at

Boo

ml of ice-

The ether layer was separated and
po~tions

of

l~

potassium bisulfite.

solutions were washed with two

then~de

50

ml

basic with lON sodium hydroxide;

during addition of the alkali, the temperature was kept below

25°.

To promote crystallization. 100 ml of methylayclohexane

was added, and the :mixture was allowed to stand.

The precipi-

tate which formed ¥as filtered and recrystallized using
.

~ethylcyclohexane.

The yield of the crystalline product was

35.0g (33% yield), mp 112-4°.
titrateable N, 6.93%.

Calculated for

c13H1 8N2 :

Found, 6.8%.

Isopropyl-2,3-epoxypropylo((J-indolylethyl)amine
-CH( CHJ )-~;CH{ CH ) 2
3
2
I

.H

~ H:;,o
H2

To.12.4g {0.13 mole ) of epichlorohydrin was added lOg
(0.05 mole) of 3-(Isopropylaminoethlidene)-indole, and the
mixture was allowed to stand over hot water (60-75°) for oneha_l.f hour.

The reaction mixture was then stored in the
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refrigerator for approximately four weeks.
stance was acidified with

50

The viscous sub-

ml of 10% acetic acid.

acid solution was extracted with

50

ml of ether.

The aqueous

portion was treated with excess 6N sodium hydroxide.
layer which separated was taken up in

The acetic

25 ml of ether.

The oily
To the

mixture was added 10 ml of acetic anhydride, and it was allowed
to stand about 15 minutes.

An oil, the acetate of the amine,

came out of solution and was drawn off.
strongly basic with

50%

The solution was made

sodium hydroxide.

the top was extracted with 10 ml of ether.

An oil which rose to
The ether was re-

moved by means of a rotary evaporator and a clear oil remained.
Calculated for c 1 6H22 No: titrateable N, 5.43%. Found, 5.9%.
l-[3-Indolylethylisopropylamino]-3(3-diethylaminopropyl)-2-

p~-i:~i-~::
~

1~

CHOR

I

CH2N-CH2-CH2 -CH2 N(C 2H5) 2
H

A mixture of 12g (0.13 mole) of epichlorohydrin and lOg
(0.05 mole) of 3-Indolylethylisopropylamine was heated in a
hot-water bath (75°) for half an hour.
solution was dissolved in

50

The resulting red

ml of ether and extracted with

lOOml of 15% acetic acid.

The aqueous layer was made basic

with 6N sodium hydroxide.

The oil which separated was extracted

with

25

ml of ether.

To this solution was added 6g (0.046 mole)

of diethylaminopropylamine and the resulting solution allowed
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to stand for several minutes.

The ether was evaporated and

the residue was treated with excess dilute acetic acid.

The

solution was extracted with .50 ml of ether, and the e.ther
layer was made basic with 6N sodium hydroxide, and the oil
which separated was treated with dilute acetic acid.

The pH

of the solution was adjusted to 7, and the solution was extracted
with 20 ml of ether.

The aqueous layer was made basic with

6N sodium hydroxide, and the oil which separated was dried and
analyzed.

Calculated for

c23 H40 N4 o:

titrateable N, 10.82%.

Found, 11.2%.

3- [3-(hydroxy)piperidinomethyl indole]

Q:J-c~QOH
H

To a solution of 4.5g (0.0.5 mole) of 3-hydroxypiperidine
dissolved in 1.5 ml of acetic acid was added 7.5g (0.07.5 mole)
of indole dissolved in 10 ml of acetic acid, keeping the
temperature below 20°.

To the cooled mixture was added slowly

10 ml of formaldehyde keeping the temperature below 10°.

The

mixture was allowed to stand at room temperature for one hour
and then poured slowly with swirling into 250 ml of ether.
The mixture was poured into three (3) different 2.50 ml volumes
of ether.

Each time the ether was discarded.

The aqueous

layer was diluted with 100 ml of water and extracted again
with 150 ml ether.

Excess sodium hydroxide was added to the
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aqueous layer, and a viscous oil appeared.

The mixture was

stirred well, but the product did not crystallize.
was decanted off.

The product was dissolved in ether, and the

ether was vacuum evaporated.
Calculated for

The water

c14H18 N2 o:

The residue crystallized.

titrateable N, 6.09%.

Found, 6.09%.

3-[3-(methanesulfonoxy)piperidinomethyl indole]

(Jt:J-CH2-QS02CH3
H

To 2.05g (0.009 mole) of 3-[3-(hydroxy)piperidinomethyl
indole] in 10 ml of pyridine was added ll.5g (0.01 mole) of
methanesulfonyl chloride, keeping the temperature at 0-10°.
After addition was complete, the reaction mixture was allowed
to come to room temperature and was poured into 200 ml of icewater containing 6 ml of 6N sodilllll hydroxide.

An oil separated.

The ice-water was decanted, and the oil was extracted with
40 ml of ether.

The ether was removed with suction under vacuum.

A hot-water bath (95°) was used to speed up the evaporation.
These conditions were too drastic, and the compound polymerized.
In another similar run there was obtained an oil which gave
the following analysis.
able N, 4.54%.

Calculated for c 15H20 N2 04s:

Found, 4.6%.

titrate-
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3-[4-(hydroxy)piperidinomethyl

indol~

O:;JCH2Q-0H
To a solution of 4.5g (0.05 mole) of 4-hydroxypiperidine
dissolved in 15 ml of acetic acid was added 7.5g (0.075 mole)
of indole dissolved in 10 ml of acetic acid, keeping the
temperature below 20°.

To the cooled mixture was added slowly
0

10 ml of formaldehyde keeping the temperature below 10 .

The

mixture was allowed to stand at room temperature for three (3)
hours and then poured into two (2) different 250 volumes of
ether as the flask was swirled.
discarded.

Each time the ether was

To the oily product was added 250 ml of water and

25 ml of acetic acid.

The mixture was extracted with three (3)

125 ml volumes of ether, each time discarding the ether.

The

aqueous layer was made basic, and the oil which separated was
extracted with 50 ml of ether.

The ether was filtered, evap-

orated, and an-&ily product was obtained.
C14H1BN2 o:

titrateable N, 6.09%.

Calculated for

Found, 6.39%.

3-[4-(methanesulfonoxy)piperidinomethyl indole]

O::J-CH2Qoso2CH3
H

In a similar manner in the run with 0.52g (0.0023 mole)
of 3-(4-hydroxypiperidino indole} in lOml of pyridine and
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o.34g (0.003 mole) of methanesulfonylchloride, the product
polymerized.

In another similar run there was obtained an

oil which gave the following analysis.
C15H20N204S:

tritrateable N, 4.54%.

Calculated for
Found, 4.3%.
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Analytical
Titration Method
The purity of all of the compounds prepared in this work
was determined by titration of the basic nitrogen atom(s) using
glacial acetic acid as solvent and 0.0903N perchloric acid in

8

glacial acetic acid as the titrant. 5

The following compounds,

for example, would contain:
O::J-CH2 CH2 N(

CH2 -~H2 } 2

R

one titrateable nitrogen atom

Equipment:

Beclanen Glass Electrode pH meter

Reagents:

Reagent grade glacial acetic acid, 0.0903N
perchloric acid in glacial acetic acid.

Procedure:

A sample ranging from 0.05g-O.lg is weighed into

a 250 ml beaker.

'.Ihe sample is dissolved in 35-50 ml of

glacial acetic acid.

Using a pH meter to follow the change

in potential of the solution, the sample is titrated with
perchloric acid in glacial acetic acid.

Increments of 0.10 ml
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are added to the solution until the endpoint is approached.
The perchloric in glacial acetic acid is then added in
increments of 0.05 ml and the endpoint is indicated by the
greatest change in potential per O.OS ml increment of acid.

Calculations:
Molecular Weight = ~-A_..x;,.._;..w~t~·--__;;;s~a-m~p~l~e_...x;.,_;;l~O~O~O;,....;..~
ml acid x N of acid
%Nitrogen=

~-A__x
____
l4..........0~_x___l_O_O__~

Molecular weight
A = Number or titrateable nitrogen atoms in both cases
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